Jesper Frank Bastlund

Title: Jesper Frank Bastlund: Innovator in Epilepsy Treatment

Introduction

Jesper Frank Bastlund is a notable inventor based in Valby, Denmark. He has made significant contributions to the field of pharmacology, particularly in the development of treatments for epilepsy and seizures. His innovative work focuses on activating Kv7 potassium channels, which play a crucial role in neuronal excitability.

Latest Patents

Jesper holds a patent for "Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or seizures." This invention provides novel compounds that activate Kv7 potassium channels, offering potential therapeutic benefits for disorders responsive to this activation. The patent outlines pharmaceutical compositions that include these compounds, emphasizing their utility in treating epilepsy and related conditions.

Career Highlights

Jesper Frank Bastlund is associated with H. Lundbeck A/S, a leading global pharmaceutical company specializing in brain diseases. His work at Lundbeck has been instrumental in advancing research and development in neurological treatments. With a focus on innovative solutions, he continues to contribute to the field through his research and patent activities.

Collaborations

Jesper has collaborated with notable colleagues, including Jian Hong and Morten Grupe Larsen. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic approaches.

Conclusion

Jesper Frank Bastlund's contributions to the field of epilepsy treatment through his innovative patent demonstrate his commitment to advancing medical science. His work at H. Lundbeck A/S and collaborations with esteemed colleagues further highlight his impact on the pharmaceutical industry.